(Q43542038)

24 November 2017

title

Mechanisms of opsonized HIV entry in normal B lymphocytes (English)

1 reference

24 November 2017

Legendre C

1

1 reference

24 November 2017

Gras G

2

1 reference

24 November 2017

Krzysiek R

3

1 reference

24 November 2017

Galanaud P

4

1 reference

24 November 2017

Richard Y

5

1 reference

24 November 2017

Dormont D

6

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 March 1996

1 reference

24 November 2017

1 reference

24 November 2017

volume

381

1 reference

24 November 2017

issue

3

1 reference

24 November 2017

page(s)

227-232

1 reference

Establishment of retrovirus-, Epstein-Barr virus-positive B-lymphoblastoid cell lines derived from individuals at risk for acquired immune deficiency syndrome (AIDS)

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900040-3

HIV and human complement: mechanisms of interaction and biological implication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900040-3

CD4 mRNA expression in CD19-positive B cells and its suppression by the Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900040-3

Complement activation is associated with the presence of specific human immunodeficiency virus (HIV)-anti-HIV immune complexes in patients with acquired immunodeficiency syndrome-related complex or lymphoadenopathy syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900040-3

Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900040-3

The AIDS-associated retrovirus is not sensitive to lysis or inactivation by human serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900040-3

Complement-mediated antibody-dependent enhancement of HIV-1 infection requires CD4 and complement receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900040-3

CR1 (CD35) and CR3 (CD11b/CD18) mediate infection of human monocytes and monocytic cell lines with complement-opsonized HIV independently of CD4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900040-3

Complement receptor 2 mediates enhancement of human immunodeficiency virus 1 infection in Epstein-Barr virus-carrying B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900040-3

Complement receptor type 2 mediates infection of the human CD4-negative Raji B-cell line with opsonized HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900040-3

CR1(CD35) and CR2(CD21) complement C3 receptors are expressed on normal human thymocytes and mediate infection of thymocytes with opsonized human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900040-3

A human immunodeficiency virus type 1 (HIV-1) infection-enhancing factor in seropositive sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900040-3

Antibody-dependent enhancement of human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900040-3

Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900040-3

Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900040-3

Evidence for the role of CR1 (CD35), in addition to CR2 (CD21), in facilitating infection of human T cells with opsonized HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900040-3

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900040-3

Complement Activation by gp160 Glycoprotein of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900040-3

Detection by in situ hybridization of HIV and c-myc RNA in tumour cells of AIDS-related B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900040-3

Complement receptors: another port of entry for HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2896%2900040-3

10.1016/0014-5793(96)00040-3

21 January 2018

Identifiers

DOI

1 reference

24 November 2017

1 reference